Vinit Nijhawan (He/Him)

At Everest Biolabs, we’re dedicated to reaching excellence in EV research by relentless focus on high-quality, easy-to-use tools for exosome and EV isolation and analytics. Our solutions are designed to enhance researchers’ daily workflows, from foundational EV isolation to advanced analytics, enabling groundbreaking discoveries. With a vision to unlock the potential of EVs in clinical applications, we keep ‘science first’ while fostering innovation and integrity in everything we do. Based in Boston, MA we’re here to elevate exosome research at every step. Launch products include: Ascent: automated, high-throughput EV isolation with SEC columns • Run up to 8 columns in parallel • Collect up to 12 fractions per column • Wash up to 8 columns • Compatible with different column types • Programmable fraction collection sequences Apex: High performance SEC columns • Available with two gel types: 4B (highest purity) & 6B (highest yield) • Sample volume 0.5-1.0 mL Atlas ELISA Kits: Easy and reliable concentration and purity assays • Run direct from biofluid or SEC fractions • Purity ELISA measures human serum albumin (HSA) • Run 8 wells at a time or the full plate • Only 50 μL of sample – no need to purify or concentrate Altas ELISA reader: Compact, high-performance absorbance reader • Measure 96 wells at once • Get results in seconds • Space-saving format

ClearCut Surgical was created by surgeons for surgeons to solve a universally frustrating operating room problem: how to manage fluid buildup during tissue electrocautery. Through surgeon-driven innovation, ClearCut has developed a novel electrocautery surgical tool with continuous smoke evacuation and on-demand fluid suction.

Eden is a leader in sustainable natural resource recovery. We break rocks with electricity to maximize subsurface permeability. We believe that a more sustainable approach to natural resource recovery is critical to creating a carbon-neutral future. By using high-voltage electricity and proprietary modeling and reservoir characterization techniques, we can achieve precise fracture permeability enhancement, while preventing the high-water consumption and environmental risks associated with traditional hydraulic fracturing operations. With backing from public and private institutions, our next-generation rock permeability enhancement technology is being demonstrated in multiple geologies across the world. We’re working with industry leaders in geothermal energy, geologic hydrogen, carbon storage, and mining to redefine how we recover Earth’s natural resources. To learn more about Eden and our groundbreaking technology, visit edengeopower.com

InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.

AeroShield is developing super-insulating, transparent inserts for windows, bringing state-of-the-art thermal comfort and energy savings into buildings at an affordable price. We work with insulated-glass manufacturers to integrate our material inside of new windows, ready to install in your home. AeroShield’s material is a breakthrough in silica aerogel research. Developed at MIT by co-founder Dr. Elise Strobach, AeroShield is the first silica aerogel to achieve optical quality comparable to glass. Our patent-pending nanostructure and proprietary manufacturing process open a world of possibilities in transparent insulation.

The problems posed by climate change need no introduction – it is one of the most pressing challenges of our era. Rapid development of clean energy storage technology is critical to combating this plague. In fact, electrification of the world’s vehicle fleet could alone cut global greenhouse gas emissions by a staggering 16%. Despite the huge commercial and environmental impact of electrification, many market segments remain unserved or under-served by current lithium-ion battery technology. Real, meaningful progress will require a new battery paradigm with charge times comparable to gasoline refueling times and cycle lifetimes that can sustain 20-years of operation. Adden Energy is scaling up a new type of solid-state battery, initially developed by a team of scientists at Harvard University, to commercially relevant cell sizes. With demonstrated charge times as low as 3 minutes and capacity retention for over 10,000 cycles in a lab-scale cells, Adden Energy’s scaling of this technology would contribute greatly to a cleaner future.

Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies. Developed at MIT, the Flowfect® platform, harmonizing microfluidics and automation, revolutionizes the delivery of genome engineering materials to cells of therapeutic interest in an expeditious, scalable, and economically advantageous manner compared to current alternatives. In May 2023, Kytopen unveiled the Flowfect Discover™, an automated high-throughput genome engineering platform, and disclosed strategic partnerships with industry-leading Contract Development and Manufacturing Organizations (CDMOs) and translational academic medical centers. By combining Flowfect Discover™ with the Flowfect Tx™ large-scale delivery device in process development workflows, developers can now surmount manufacturing challenges during the discovery stage, fostering swifter and more cost-effective innovation.

Concerto Biosciences reinvents humanity’s relationship with microbes. We envision a future where each of us fine-tunes the microbial communities in us, on us, and around us to stay healthy. To pave the way, Concerto invented a platform to measure, in ultra-high throughput, how microbes behave in the presence of each other. These measurements enable Concerto to see the world as it is: a massive underlying network of microbial interactions that shapes the health of our bodies and our planet. The network reveals new products—“ensembles” of microbes that work in concert to perform tasks that benefit people. Our first ensembles rehabilitate the skin microbiome, providing protection from previously intractable diseases like eczema and restoring health to millions.

LearnLaunch Institute, is a non-profit organization, located in Boston, serving the education ecosystem in the New England region. We believe in high-quality, equitable teaching and learning for all students. We help unleash the power of innovation by empowering school & district leaders to embrace & manage change. We engage education practitioners and policy leaders in workshops and conferences. We convene local, state, and national thought leaders to solve the toughest problems facing education. We lead communities to muster the power of innovation. Learn more at learnlaunch.org and follow LearnLaunch on Twitter at @learnlaunch. Learn more about the LearnLaunch Accelerator at learnlaunch.com.

Solera is a leading global provider of integrated vehicle lifecycle and fleet management software-as-a-service, data, and services. Through four lines of business – vehicle claims, vehicle repairs, vehicle solutions and fleet solutions – Solera is home to many leading brands in the vehicle lifecycle ecosystem, including Identifix, Audatex, DealerSocket, Omnitracs, Spireon, LoJack, eDriving/Mentor, Explore, cap hpi, Autodata, and others. Solera empowers its customers to succeed in the digital age by providing them with a “one-stop-shop” solution that streamlines operations, offers data-driven analytics, and enhances customer engagement, which Solera believes helps customers drive sales, promote customer retention, and improve profit margins. Solera serves over 300,000 global customers and partners in 100+ countries. For more information, visit www.solera.com.

At Everest Biolabs, we’re dedicated to reaching excellence in EV research by relentless focus on high-quality, easy-to-use tools for exosome and EV isolation and analytics. Our solutions are designed to enhance researchers’ daily workflows, from foundational EV isolation to advanced analytics, enabling groundbreaking discoveries. With a vision to unlock the potential of EVs in clinical applications, we keep ‘science first’ while fostering innovation and integrity in everything we do. Based in Boston, MA we’re here to elevate exosome research at every step. Launch products include: Ascent: automated, high-throughput EV isolation with SEC columns • Run up to 8 columns in parallel • Collect up to 12 fractions per column • Wash up to 8 columns • Compatible with different column types • Programmable fraction collection sequences Apex: High performance SEC columns • Available with two gel types: 4B (highest purity) & 6B (highest yield) • Sample volume 0.5-1.0 mL Atlas ELISA Kits: Easy and reliable concentration and purity assays • Run direct from biofluid or SEC fractions • Purity ELISA measures human serum albumin (HSA) • Run 8 wells at a time or the full plate • Only 50 μL of sample – no need to purify or concentrate Altas ELISA reader: Compact, high-performance absorbance reader • Measure 96 wells at once • Get results in seconds • Space-saving format

ClearCut Surgical was created by surgeons for surgeons to solve a universally frustrating operating room problem: how to manage fluid buildup during tissue electrocautery. Through surgeon-driven innovation, ClearCut has developed a novel electrocautery surgical tool with continuous smoke evacuation and on-demand fluid suction.

Eden is a leader in sustainable natural resource recovery. We break rocks with electricity to maximize subsurface permeability. We believe that a more sustainable approach to natural resource recovery is critical to creating a carbon-neutral future. By using high-voltage electricity and proprietary modeling and reservoir characterization techniques, we can achieve precise fracture permeability enhancement, while preventing the high-water consumption and environmental risks associated with traditional hydraulic fracturing operations. With backing from public and private institutions, our next-generation rock permeability enhancement technology is being demonstrated in multiple geologies across the world. We’re working with industry leaders in geothermal energy, geologic hydrogen, carbon storage, and mining to redefine how we recover Earth’s natural resources. To learn more about Eden and our groundbreaking technology, visit edengeopower.com

InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.